The global prevalence of gastric cancer in Helicobacter pylori-infected individuals: a systematic review and meta-analysis

M Shirani, R Pakzad, MH Haddadi, S Akrami… - BMC Infectious …, 2023 - Springer
Background Helicobacter pylori is a gastrointestinal pathogen that infects around half of the
world's population. H. pylori infection is the most severe known risk factor for gastric cancer …

Quercetin as a JAK–STAT inhibitor: a potential role in solid tumors and neurodegenerative diseases

H Zalpoor, M Nabi-Afjadi, R Forghaniesfidvajani… - Cellular & molecular …, 2022 - Springer
The Janus kinase–signal transducer and activator of transcription (JAK–STAT) pathway is
involved in many immunological processes, including cell growth, proliferation …

Colorectal cancer treatment using bacteria: focus on molecular mechanisms

S Ebrahimzadeh, H Ahangari, A Soleimanian… - BMC microbiology, 2021 - Springer
Background Colorectal cancer which is related to genetic and environmental risk factors, is
among the most prevalent life-threatening cancers. Although several pathogenic bacteria …

Human gastric microbiota analysis of refractory H. pylori infection

X Huang, D Zhang, D Li, Y Lv, S Chen, F Bai - Scientific Reports, 2024 - nature.com
H. pylori infection is gaining increasing attention, but detailed investigations into its impact
on gastric microbiota remain limited. We collected gastric mucosa samples from 47 …

幽门螺杆菌对克拉霉素, 甲硝唑和左氧氟沙星的耐药率及其相关耐药基因突变特征

宋顺佳, 王鑫莹, 姜菲菲, 贾慧建, 赵远… - 吉林大学学报(医学 …, 2022 - xuebao.jlu.edu.cn
目的: 检测幽门螺杆菌(Hp) 对3 种常见抗生素的耐药率, 探讨其相关耐药基因突变形式,
为阐明其耐药分子机制提供依据. 方法: 选择35 例确诊为慢性胃炎或消化性溃疡患者的胃黏膜 …

The Importance of Treating Helicobacter Pylori Infection: The Advantages of Non-Antibiotic

Y Shen, S Gao, R Hu - Available at SSRN 4774671 - papers.ssrn.com
Helicobacter pylori (H. pylori) is a Gram-negative microaerophilic bacterium that infects
about half of the world's population and has been classified as a Class I carcinogen by the …